PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 146 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $95,000 | -73.2% | 25,005 | -64.1% | 0.00% | – |
| Q4 2019 | $355,000 | -57.4% | 69,683 | -57.7% | 0.00% | – |
| Q3 2019 | $833,000 | +64.3% | 164,740 | +100.6% | 0.00% | – |
| Q2 2019 | $507,000 | +180.1% | 82,131 | +109.9% | 0.00% | – |
| Q1 2019 | $181,000 | -84.1% | 39,120 | -85.6% | 0.00% | -100.0% |
| Q4 2018 | $1,141,000 | +2493.2% | 271,647 | +3755.3% | 0.00% | – |
| Q3 2018 | $44,000 | +33.3% | 7,046 | +74.0% | 0.00% | – |
| Q2 2018 | $33,000 | -96.2% | 4,049 | -96.6% | 0.00% | – |
| Q1 2018 | $880,000 | +5076.5% | 118,044 | +4046.3% | 0.00% | – |
| Q4 2017 | $17,000 | -91.1% | 2,847 | -89.1% | 0.00% | – |
| Q3 2017 | $192,000 | +140.0% | 26,047 | +120.4% | 0.00% | – |
| Q2 2017 | $80,000 | -29.2% | 11,818 | -1.1% | 0.00% | – |
| Q1 2017 | $113,000 | -69.9% | 11,950 | -72.4% | 0.00% | – |
| Q4 2016 | $375,000 | +103.8% | 43,337 | +49.0% | 0.00% | – |
| Q3 2016 | $184,000 | +3.4% | 29,076 | -31.0% | 0.00% | – |
| Q2 2016 | $178,000 | +147.2% | 42,146 | +154.7% | 0.00% | – |
| Q1 2016 | $72,000 | -90.8% | 16,550 | -87.0% | 0.00% | -100.0% |
| Q4 2015 | $783,000 | +770.0% | 127,771 | +708.7% | 0.00% | – |
| Q3 2015 | $90,000 | +69.8% | 15,800 | +122.5% | 0.00% | – |
| Q2 2015 | $53,000 | +71.0% | 7,100 | +39.2% | 0.00% | – |
| Q1 2015 | $31,000 | -24.4% | 5,100 | -5.6% | 0.00% | – |
| Q4 2014 | $41,000 | – | 5,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|